Autoantibodies to ACE2 and immune molecules are associated with COVID-19 disease severity.

Eric S GeanesRebecca McLennan Cas LeMaster Todd Bradley

Published in: Communications medicine (2024)

These results demonstrate that SARS-CoV-2 infection can increase autoantibody levels to ACE2 and other immune factors. The levels of these autoantibodies are associated with COVID-19 disease severity.

Keyphrases

coronavirus disease
sars cov
systemic lupus erythematosus
respiratory syndrome coronavirus
angiotensin converting enzyme
angiotensin ii